Sponsored by:

Nuclear Medicine: Page 306

Siemens adds to Symbia line
By AuntMinnie.com staff writers
Siemens Healthcare has added a single-detector SPECT system to its Symbia molecular imaging product line.
February 18, 2009
Michael J. Fox Foundation awards neuroimaging grants
By AuntMinnie.com staff writers
The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $1.9 million in grants to develop neuroimaging techniques for visualizing the clumping of the alpha-synuclein protein in the living human brain.
February 18, 2009
GE installs first Discovery PET/CT 600 series units
By AuntMinnie.com staff writers
GE Healthcare has begun installing its first Discovery PET/CT 600 series scanners.
February 17, 2009
Chalk River back online
By AuntMinnie.com staff writers
Atomic Energy of Canada's Chalk River reactor went back online Tuesday afternoon, February 17, as scheduled.
February 17, 2009
Digirad names Slansky as CFO
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad has named Richard Slansky as its new CFO, effective March 9.
February 17, 2009
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
February 16, 2009
PET growth rate slows; achieving breast imaging excellence
By Brian Casey
February 16, 2009
Palatin posts mixed results in Q2
By AuntMinnie.com staff writers
A collaboration with British pharmaceutical firm AstraZeneca helped boost revenue for Palatin Technologies in its second fiscal quarter.
February 16, 2009
Chalk River closes again temporarily
By AuntMinnie.com staff writers
Atomic Energy of Canada was forced to shut down its Chalk River nuclear reactor on February 15 due to a problem with the mechanism that extracts isotope-containing rods from the reactor.
February 16, 2009
Growth rate for PET procedure volume slows to single digits
By James Schneider
Growth in PET and PET/CT procedure volume in the U.S. slowed to a single-digit rate in 2008 compared to 2007, as opposed to the double-digit annual growth rates the modality enjoyed before 2007, according to a new study published by IMV Medical Information Division.
February 16, 2009
2009 02 13 16 46 48 994 2009 02 17 Pet Sites Studies Cropped
MURR initiates Mo-99 production plans
By Wayne Forrest
With global supplies of molybdenum-99 (Mo-99) strained over the past two years, several initiatives are under way in the U.S. to bring production closer to home. Among the developers is the University of Missouri Research Reactor (MURR) program, which has initiated plans to build a target processing facility for Mo-99 adjacent to its current multipurpose research reactor.
February 16, 2009
Palatin nabs research cash
By AuntMinnie.com staff writers
Radiopharmaceutical developer Palatin Technologies has received cash for an extension of an exclusive research collaboration and license agreement with pharmaceutical firm AstraZeneca to develop and market compounds that target melanocortin receptors.
February 11, 2009
Previous Page
Page 306 of 440
Next Page